Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
King Abdulaziz University holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The university currently has 4 pending office actions. These actions are distributed among 4 distinct examiners and 4 distinct art units. This high level of dispersion means that every pending matter is being handled by a different examiner in a different specialized unit.
QIAN, SHIZHI is the busiest examiner for the portfolio, with 1 busiest examiner pending office action. Given that there are 4 pending office actions and 4 distinct examiners, each examiner is responsible for 1 action. The fact that there are also 4 distinct art units indicates a range of biotechnology and pharmaceutical research being patented. This diversity requires a flexible prosecution strategy, as the university must interact with 4 different administrative groups, each with its own examination culture and technical focus across the 4 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| QIAN, SHIZHI | 1 | 61.8% | +47.9% |
| BAUER, BRIANNA LEE | 1 | 100.0% | +0.0% |
| GRIZER, CASSANDRA SENN | 1 | 75.0% | +18.8% |
| LING, FOR K. | 1 | 53.7% | +18.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18601388 | IMIDAZOLE HETEROCYCLE BASED COMPOUNDS AND METHODS OF TREATING CANCER | BAUER, BRIANNA LEE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18461835 | PRODUCTION OF ELISA REAGENTS AND VACCINES BY 'ONE PROCESS' | GRIZER, CASSANDRA SENN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18914786 | GOLD-COATED MICRO-CHIP CLOZAPINE SENSOR FUNCTIONALIZED WITH CYZ NANOSHEET | QIAN, SHIZHI | — |
| 18461835 | PRODUCTION OF ELISA REAGENTS AND VACCINES BY 'ONE PROCESS' | GRIZER, CASSANDRA SENN | — |
| 18158823 | MICROCHANNEL COMPACT HEAT EXCHANGING SYSTEM | LING, FOR K. | — |
| Art Unit | Apps |
|---|---|
| 1795 | 1 |
| 1623 | 1 |
| 1672 | 1 |
| 3763 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18914786 | GOLD-COATED MICRO-CHIP CLOZAPINE SENSOR FUNCTIONALIZED WITH CYZ NANOSHEET | QIAN, SHIZHI | 1795 | §112 | Non-Final OA | — | Pending | Oct 14, 2024 |
| 18601388 | IMIDAZOLE HETEROCYCLE BASED COMPOUNDS AND METHODS OF TREATING CANCER | BAUER, BRIANNA LEE | 1623 | §103Other | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18461835 | PRODUCTION OF ELISA REAGENTS AND VACCINES BY 'ONE PROCESS' | GRIZER, CASSANDRA SENN | 1672 | §103§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18158823 | MICROCHANNEL COMPACT HEAT EXCHANGING SYSTEM | LING, FOR K. | 3763 | §103 | Final Rejection | — | Pending | Jan 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial